AbbVie
ABBV
ABBV
3,776 hedge funds and large institutions have $264B invested in AbbVie in 2025 Q1 according to their latest regulatory filings, with 264 funds opening new positions, 1,477 increasing their positions, 1,604 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 3,707 → 3,776 (+69)
0.93% less ownership
Funds ownership: 72.13% → 71.21% (-0.93%)
8% less repeat investments, than reductions
Existing positions increased: 1,477 | Existing positions reduced: 1,604
Holders
3,776
Holding in Top 10
243
Calls
$3.94B
Puts
$3.43B
Top Buyers
| 1 | +$1.16B | |
| 2 | +$805M | |
| 3 | +$627M | |
| 4 |
Goldman Sachs
New York
|
+$598M |
| 5 |
Barclays
London,
United Kingdom
|
+$572M |
Top Sellers
| 1 | -$1.67B | |
| 2 | -$1.02B | |
| 3 | -$628M | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$455M |
| 5 |
Amundi
Paris,
France
|
-$341M |
